Viewing Study NCT07432594


Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-03-31 @ 4:43 AM
Study NCT ID: NCT07432594
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-25
First Post: 2026-02-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module